Aly-Khan Lalani
@lalaniMD
Followers
3K
Following
8K
Statuses
2K
Genitourinary Cancers Disease Site Chair, @HamHealthSci | Associate Professor, @McMasterU | Former Fellow, @DanaFarber | Host: @TheViewonGU
Toronto, Ontario
Joined February 2011
Thank you to @CAMO_ACOM leadership. This is truly an honour — with so many worthy candidates in their first 10 yrs of career. Grateful for collaborative colleagues and guiding mentors (near and far) for their ongoing support along my path! 🙏 👏 @b_dhesy @GillSharlene @camoprez
Congratulations 👏 to Dr. Aly-Khan Lalani! Recipient of the 2023 Rising Star Award 🏆 @lalaniMD @GillSharlene @camoprez @Erin19785799 #CAMO23
16
6
69
RT @DrChoueiri: 1/ JUST IN: an 8 year #kidneycancer journey now published in @Nature: “A personalized neoantigen vaccine generates anti-tum…
0
205
0
RT @TheIsmaili: Prince Rahim al-Hussaini Aga Khan V is the 50th hereditary Imam of the Shia Ismaili Muslims, as designated by Mawlana Shah…
0
497
0
RT @ReneeSaliby: 1/ 🧵Excited to share our latest study published in @NatureCancer co-led with amazing co-first authors and friends @TJammih…
0
61
0
RT @theviewongu: ⏪ Let’s rewind back to the start of 2024… and see how far we’ve come! We’ll see you in 2025 for new episodes of The View o…
0
2
0
RT @DrChoueiri: IT IS THIS TIME OF THE YEAR AGAIN! TOP 10 GU Bladder/Kidney Cancer TRIALS FOR 2024 1/ Enfortumab Vedotin (EV) + Pembroliz…
0
241
0
RT @DrChoueiri: It is this time of the Year again: 10 TOP TRANSLATIONAL PAPERS IN GU ONCOLOGY! 1/ Prostate Paper 1 Fonseca et al. introdu…
0
77
0
RT @theviewongu: Happy holidays from The View on GU team & your hosts @lalanimd & @walliscjd! We’re so proud of the community we’ve built w…
0
4
0
RT @tompowles1: 1/3 TROPICS-4: sacituzimab govitecan vs chemotherapy in heavily pretreated UC #ESMOasia24 @PGrivasMDPhD. OS & PFS HR of 0.8…
0
48
0
RT @mustafa_soytas: A great honour to be involved in this amazing study and team in enlightening of #kidneycancer by prospective real-world…
0
7
0
RT @CuaJournal: #CUAJHighlightedPaper : RCC EXPERT REPORT >>> to read @DrJeffreyGraham
@lalaniMD @PavlosMsaouel @U…
0
7
0
RT @KarlSemaan: 1/ 🚨Happy to share our piece of work entitled “Landscape of subsequent therapies in perioperative immunotherapy trials acro…
0
31
0
RT @WallisCJD: Big excitement #esmo24 regarding peri-op immunotherapy with data from NIAGARA and AMBASSADOR. Today, our aggregate data is…
0
3
0
RT @theviewongu: After spending a few days at the ESMO conference in Spain, Dr. @lalanimd & Dr. @walliscjd are eager to share everything t…
0
3
0
@WallisCJD … and we had tapas. One take pic, just like the podcasts #Barcelona #ESMO2024 #ESMO24 @theviewongu
0
2
4
RT @WallisCJD: Watch out for episodes coming soon summarizing all the top GU data including NIAGARA, TiNivo-2, SunRise-1, ARANOTE, SPLASH,…
0
1
0
RT @theviewongu: The #ViewOnGU's @lalanimd & @walliscjd have arrived at the @myESMO conference in Barcelona! While in Spain, they will of c…
0
1
0
RT @DrChoueiri: Thank you Dr. Maria De Santis for this wonderful discussion of the 3 mini-oral abstracts presented this morning! Huge stri…
0
14
0